In vitro testing showed effective silencing of the NCL/miR-211/NFkB/DNMT1 pathway, leading to the synergistic arrest of AML cell proliferation; corroborated by the in vivo testing with extension of AML mice survival with disease regression [142]. This evidence concerns the gene DNMT1 and acute myeloid leukemia.